Zobrazeno 1 - 10
of 7 079
pro vyhledávání: '"motor-symptoms"'
Autor:
Mohammad Amin Karimi, Alireza Ghajari, Reza Khademi, Mohammad Hossein Etemadi, Narges Safar Firouz, Behnaz Mohammadvand, Kimia Janeshin, Afra Darvishi, Shafagh Asgarzadeh, Sayedeh-Fatemeh Sadat-Madani, Mohammad Abbasalizadeh, Zahra Jafari Shendi, Ata Akhtari Kohnehshahri, Niloofar Deravi, Seyed Amirhossein Mazhari, Mahsa Aziz, Matin Bidares, Mohaddeseh Belbasi, Mahdyieh Naziri, Hossein Ashkpour Motlagh
Publikováno v:
IBRO Neuroscience Reports, Vol 17, Iss , Pp 207-219 (2024)
Background: Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by dopamine depletion and severe motor impairments. Preladenant, an adenosine A2 receptor antagonist, is an investigational treatment for PD. This systematic r
Externí odkaz:
https://doaj.org/article/9327aa8a9c8b4c3c9183f771774b0db9
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Parkinson’s disease (PD) is characterized by motor and non-motor symptoms. Cognitive decline is crucial in disease progression and affect quality of life; however, their underlying mechanisms in PD remain unclear. We explored the relations
Externí odkaz:
https://doaj.org/article/485bc77e04a448a3ac89e3052ed782b3
Publikováno v:
International Journal of General Medicine, Vol Volume 17, Pp 5059-5068 (2024)
Mohamed Sheikh Hassan,1 Nur Adam Mohamed,2 Yavuz Yücel,3 Yusuf Abdirisak Mohamed,2 Alper Gökgül1 1Department of Neurology, Mogadishu Somalia Turkiye Training and Research Hospital, Mogadishu, Somalia; 2Department of Psychiatry and Behavioral Scien
Externí odkaz:
https://doaj.org/article/208c494752db4e3796a9772f900510e5
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 18, Iss 3, Pp 72-80 (2024)
Motor and non-motor symptoms of Parkinson’s disease (PD) and their management have been evaluated in numerous studies. Four classical symptoms, including bradykinesia, tremor, rigidity, and postural abnormalities, are used to establish a clinical d
Externí odkaz:
https://doaj.org/article/e6fb0adac4b74f36a3b3c5deb47b62b7
Publikováno v:
Open Medicine, Vol 19, Iss 1, Pp 939-53 (2024)
Parkinson’s disease (PD) is primarily known as a motor disorder; however, its debilitating non-motor symptoms have a significant impact on patients’ quality of life. The current standard treatment, l-DOPA, is used to relieve motor symptoms, but p
Externí odkaz:
https://doaj.org/article/a57df5f84b734b09b9c42a8f8adfa887
Autor:
D. J.L. Stikvoort García, B. T.H.M. Sleutjes, W. Mugge, J. J. Plouvier, H. S. Goedee, A. C. Schouten, F. C.T. van der Helm, L. H. van den Berg
Publikováno v:
Journal of NeuroEngineering and Rehabilitation, Vol 21, Iss 1, Pp 1-11 (2024)
Abstract Background Amyotrophic lateral sclerosis (ALS) is a lethal progressive neurodegenerative disease characterized by upper motor neuron (UMN) and lower motor neuron (LMN) involvement. Their varying degree of involvement results in a clinical he
Externí odkaz:
https://doaj.org/article/d2449547ea224e9697cfaa8c8803f34d
Autor:
Ann Liebert, Brian Bicknell, E-Liisa Laakso, Sharon Tilley, Gillian Heller, Hosen Kiat, Geoffrey Herkes
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Parkinson’s disease is a progressive neurodegenerative disease characterized by clinical motor signs and non-motor symptoms that severely impact quality of life. There is an urgent need for therapies that might slow, halt or eve
Externí odkaz:
https://doaj.org/article/362937c6d7ee4cdeaf82396470e351e4
Autor:
V. Andreozzi, S. Cuoco, M. Balestrieri, F. Fierro, N. Ferrara, R. Erro, M. Di Filippo, G. Barbella, M. C. Memoli, A. Silvestri, M. Squillante, S. Guglielmetti, P. Barone, P. Iovino, M. T. Pellecchia
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Gut microbiota changes and brain-gut-axis (BGA) dysregulation are common in people with Parkinson’s Disease (PD). Probiotics and prebiotics are emerging as a potential therapeutic approach for PD patients. The aim of this paper was to asse
Externí odkaz:
https://doaj.org/article/8776248fc6fe419abbbb80ca67dced9b
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e38645- (2024)
Background: Parkinson's disease (PD) is a global neurodegenerative ailment impacting millions, causes significant degeneration of dopaminergic neurons in the substantia nigra. Emerging research underscores the gut microbiota's role in PD onset. Yet,
Externí odkaz:
https://doaj.org/article/b985423a63ce402591a3c6b59a3de6fe
Autor:
Olga Szeidl, Joanna Szydziak, Aleksandra Hrapkowicz, Kinga Janowska, Dominika Rehan, Julia Wołoszczak, Agnieszka Mioskowska, Daria Dąbkowska
Publikováno v:
Quality in Sport, Vol 31 (2024)
Purpose of the Study: This review examines the role of Deep Brain Stimulation (DBS) as a therapeutic intervention for advanced PD, focusing on indications, patient selection criteria, and potential complications. Materials and Methods: A comprehensiv
Externí odkaz:
https://doaj.org/article/bddfb0fe05354f2788b848d8f58cd985